0-28456
|
65-0635748
|
(Commission
file number)
|
(I.R.S.
Employer Identification No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17
CFR240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the ExchangeAct (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act(17 CFR
240.13e-4(c))
|
Name
|
Title
|
Number
of Shares to be Repurchased
|
Total
Repurchase
Price
|
|||
Dr.
Martin W. Harrison
|
Director
|
250,000
|
$536,550
|
|||
Karl
M. Sachs
|
Director
|
230,000
|
$493,626
|
|||
Robert
J. Sabo
|
Chief
Financial Officer
|
20,000
|
$42,924
|
Name
|
Title
|
Number
of Options to be Repurchased
|
Total
Repurchase
Price
|
|||
Dr.
Jose A. Guethon
|
President
and Chief Operating Officer
|
300,000
|
$70,360
|
|||
Roberto
L. Palenzuela
|
General
Counsel
|
267,500
|
$261,558
|
METROPOLITAN HEALTH NETWORKS, INC. | |||
|
By:
|
/s/ Roberto L. Palenzuela | |
Roberto L. Palenzuela | |||
Secretary and General Counsel | |||